Skip to main content
Premium Trial:

Request an Annual Quote

GenoMed Applies for Amex Listing as Nasdaq OTC Plan Idles

NEW YORK, July 6 (GenomeWeb News) - GenoMed plans to move from the Pink Sheets over-the-counter market to a listing on the American Stock Exchange.

 

The company said today that it expects to hear from Amex about the status of its application within six to eight weeks. GenoMed's stock is currently traded on the Pink Sheets under the ticker symbol GMED.

 

In November 2002, GenoMed announced plans to trade on the Nasdaq over-the-counter bulletin board. David Moskowitz, CEO and chief medical officer of the company, told GenomeWeb News today that changes in accounting rules and other factors led to a number of delays in the approval process. "We never got an official denial, but we certainly didn't get an approval either," he said.

 

Moskowitz said the company has a good chance of meeting the primary requirement for trading on Amex -- a market capitalization of $50 million. The company has around 200 million shares outstanding, and Moskowitz said he is confident the company can hit and maintain a $0.25 share price to reach the $50 million market cap milestone.

 

GenoMed's stock was trading at $0.185 as of 12:30 EDT today, after opening at $0.16.

 

Many brokers avoid Pink Sheet stocks, Moskowitz said, so a move to Amex is expected to increase investor confidence and improve the company's liquidity.

The Scan

Omicron's Emergence

The World Health Organization has called Omicron a SARS-CoV-2 "variant of concern," the Los Angeles Times writes.

Not as Much

Merck's pill to treat COVID-19 reduces the risk of hospitalization and death among COVID-19 patients by less than previously reported, the New York Times says.

Bats That Hang Together

Discover magazine writes that researchers have found a social microbiome among vampire bats.

PLOS Papers on CEWAS, Simian Varicella Virus Transcriptome, Dermatomyositis Markers

In PLOS this week: multi-omic approach to home in on genetic risk variants, transcriptomic analysis of the simian varicella virus, and more.